GeneralConnection.com
➔
Dictionary
Dictionary Search
Go Find!
tarsus
Synonyms
Noun
1. skeletal structure
Usage
Patriarch Mor John X ordains Archimandrite Paul Orduluoğlu as Bishop of Tarsus in Mersin - SyriacPress
Episcopal ordination of Archimandrite Paul Ordologlou as Bishop of Tarsus (PHOTOS) - Orthodox Times
Tarsus Pharmaceuticals stock price target cut to $100 by Mizuho on revenue outlook - Investing.com
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Share Price Moves And Ongoing Losses - Yahoo Finance
Owl Bracelet Tarsus Friend Gifts For Women Christian Gifts For Women Adjustable Bracelet With Extension Chain - primetimes.id
Tarsus Pharmaceuticals: Marketing Spend Bears Fruit, Pipeline Progresses (NASDAQ:TARS) - Seeking Alpha
The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following First Dosing In TP-05 Lyme Trial - simplywall.st
Tarsus Pharmaceuticals Reports $451.4 Million in XDEMVY® Sales for Full-Year 2025 and Announces New Clinical Trials for Ocular Rosacea and Lyme Disease Prevention - Quiver Quantitative
Paul of Tarsus: Cultural Amphibian - The Catholic Thing
Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential (NASDAQ:TARS) - Seeking Alpha
How TP-05’s Phase 2 Lyme Prophylaxis Trial Progress Could Impact Tarsus Pharmaceuticals (TARS) Investors - Yahoo Finance
Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease - Yahoo Finance
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating - Yahoo Finance
Tarsus Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance - Yahoo Finance
Tarsus Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After Adding Former Allergan CEO David Pyott To Its Board - Yahoo Finance
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? - Yahoo Finance
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade - The Motley Fool
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Celebrating confirmations at St. Paul of Tarsus Parish in Clinton Township - Detroit Catholic
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Stocks With Rising Relative Strength: Tarsus Pharmaceuticals - Investor's Business Daily
Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next - Yahoo Finance
Cherry Bekaert Bolsters Outsourced Accounting Services With Acquisition of Washington, DC-Based Firm Tarsus - PR Newswire
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After TP-05 Phase 2 Lyme Disease Trial Begins - simplywall.st
Q2 net sales reach $100M for Tarsus’ XDEMVY, with pipeline potential for Lyme rooted in animal health - drugdiscoverytrends.com
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in - GlobeNewswire
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Cherry Bekaert snaps up Washington-based accounting practice Tarsus - International Accounting Bulletin
Tarsus Pharmaceuticals Stock Earns Upgrade To RS Rating - Investor's Business Daily
Lessons in Category Creation: In Conversation with Bobby Azamian, CEO Tarsus Pharmaceuticals - Endpoints News
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical - GlobeNewswire
Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors - VisionMonday.com
Tarsus Reports Soaring Xdemvy Sales in Q4, Full Year - Orange County Business Journal
Former Allergan CEO David Pyott joins Tarsus Pharmaceuticals board - Investing.com
Tarsus Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - VisionMonday.com
First patient dosed in 700-person study to prevent Lyme disease - Stock Titan
Tarsus Adds Former Allergan CEO to Board - Orange County Business Journal
Tarsus doses first patient in Lyme disease prevention trial - Investing.com
Navigating the 2026 data deluge: How Tarsus Distribution and Dell Technologies storage keep your business agile - MyBroadband
Tarsus earns $15M milestone on China approval of eye drug - Investing.com
Farrow Jeffrey S of Tarsus Pharma sells $439k in shares - Investing.com
China clears first Demodex blepharitis treatment for 40 million people - Stock Titan
William Blair reiterates Outperform on Tarsus Pharmaceuticals stock - Investing.com
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative - simplywall.st
Tarsus Pharma general counsel Wahl sells $850k in stock - Investing.com
Cherry Bekaert Acquires Tarsus to Strengthen Outsourcing, CFO Advisory Services - GovCon Wire
Does Tarsus Pharmaceuticals (NASDAQ:TARS) Have A Healthy Balance Sheet? - simplywall.st
Tarsus Pharmaceuticals (TARS) COO sells 2,989 shares in planned trade - Stock Titan
Shareholders Should Be Pleased With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Price - simplywall.st
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader - The National Law Review
Cherry Bekaert acquires Tarsus - Accounting Today
Tarsus Pharmaceuticals (TARS): Losses Widen Despite Strong Growth Outlook, Challenging Bullish Narratives - Yahoo Finance
Tarsus Pharmaceuticals shares rise on China drug approval milestone - Investing.com
Earnings call transcript: Tarsus Pharmaceuticals Q4 2025 sees robust growth - Investing.com
Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals (TARS) Welcomes Former Allergan CEO to Bo - GuruFocus
Tarsus Pharmaceuticals: Xdemvy Momentum Continues In Q3 (NASDAQ:TARS) - Seeking Alpha
Cherry Bekaert acquires CPA outsourcing firm - Business North Carolina
Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha
What's Next For Tarsus As Cash Reserves Fuel Pipeline And Global Reach? - RTTNews
Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade - AOL.com
Tarsus to Participate in Upcoming Investor Conference - GlobeNewswire
Tarsus Pharmaceuticals (TARS) files Section 144 notice to sell 12,500 shares - Stock Titan
Possible Bearish Signals With Tarsus Pharmaceuticals Insiders Disposing Stock - simplywall.st
Heritage on a plate: How EU support is helping to preserve Tarsus cuisine - EEAS
Tarsus Pharma COO Neervannan Seshadri sells $772k in shares - Investing.com
Tarsus Q3 2025 presentation slides: XDEMVY sales surge 147% YoY to $118.7M - Investing.com
Tarsus Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Sarı Ulak Olive Festival - Slow Food
"Reviving" Paul of Tarsus: a necessity for the contemporary Church - omnesmag.com
Mizuho raises Tarsus Pharmaceuticals stock price target on China approval - Investing.com
Tarsus Pharmaceuticals Stock Jumps on China Breakthrough - TipRanks
Felix Tarsus George Obituary January 4, 2026 - Serenity Funeral Home | Kansas City, MO
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS), Climb Bio (CLYM) and Boston Scientific (BSX) - The Globe and Mail
Tarsus Pharmaceuticals Chief Human Resources Officer Sells Shares, Transaction Highlights Company’s Commercial Momentum - NAI500
Why Tarsus Pharmaceuticals Shares Are Dropping Today - TipRanks
Şişecam Commissioned New Energy Glass Lines in Tarsus - glassonweb.com
Raleigh accounting firm expands D.C. presence with acquisition - The Business Journals
Tarsus Pharmaceuticals Outpaces Expectations On XDEMVY Sales Growth - Finimize
Tarsus Pharmaceuticals stock hits all-time high at 83.67 USD By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals shares rise on China drug approval milestone By Investing.com - Investing.com South Africa
Heritage on a plate in Türkiye's Tarsus as EU-backed center keeps living kitchen alive - Türkiye Today
Is Tarsus Pharmaceuticals (TARS) Stock Consolidating | Price at $71.50, Up 1.97% - Insider Buying - Cổng thông tin điện tử Tỉnh Sơn La
Tarsus Group Buys 80-percent Stake in Connect Meetings - Trade Show News Network
Kobanê native Baran Abdî killed in Tarsus - ANF | Articles
Equine Standing Multidetector Computed Tomography of the Distal Thoracic Limb and Tarsus Has a Lower Cumulative Radiation Dose than Digital Radiography - Wiley Online Library
Besiktas - Tarsus 100:70 - Flashscore.com
Mersin Çayspor vs Tarsus Yıldırımspor live score, H2H and lineups - Sofascore
Fenerbahce - Tarsus 108:66 - Flashscore.com
Where Are They Now? Tarsus Pharmaceuticals - Life Science Leader
Tarsus Pharmaceuticals: Record Revenue Masks Deepening Losses - AD HOC NEWS
Martyr Julian of Tarsus, in Cilicia (June 21) - Greek City Times
Tarsus Barbarosspor vs Gülnar Belediyespor live score, H2H and lineups - Sofascore
Botaş vs Tarsus scores & predictions - Sofascore
Foreign Language Equivalents
Foreign Language Equivalents of 'tarsus'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
tarrsus, tarss, tarssu, tarssus, tatsus, tarsua, rarsus, yarsus, tasrus, trsus, tarsis, taraus, arsus, tsrsus, atrsus, tarsu, taruss, tarsuus, tarsuss, tardus, tarus, tarsud, taesus, trasus, tasus, taarsus, tarsys, ttarsus
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z